Page 32 - Patco News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Patco. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Patco Today - Breaking & Trending Today
The drug maker signed a royalty-free, non-exclusive, voluntary licensing agreement with Eli Lilly and Company, for the manufacture and commercialization of the drug Baricitinib for COVID-19 indication in India. In line with the licensing agreement, Natco Pharma has withdrawn its application filed with the Indian Patent Office, seeking Compulsory License against Lilly for Baricitinib for COVID-19 in India. Natco Pharma had earlier received an emergency use authorization for Baricitinib tablets, from Central Drugs Standard Control Organization (COSCO), for use in combination with remdesivir, for the treatment of suspected or laboratory confirmed COVID-19 in hospitalized adults requiring supplemental oxygen, invasive mechanical ventilation, or extracorporeal membrane oxygenation (ECMO). ....
Natco Pharma to further expedite the availability of baricitinib for COVID-19 patients in India. The company has issued an additional royalty-free, non-exclusive voluntary license to Natco Pharma and the Hyderabad-based company will be collaborating with Eli Lilly to further accelerate and expand the availability of baricitinib in India during this pandemic. The move will improve the local treatment options available and will positively impact the lives of people who are currently battling COVID-19 in India, Eli Lilly said in a statement. Earlier, the company had announced signing of six voluntary license agreements with Cipla, Lupin, Sun Pharmaceutical Industries, Dr Reddy s, MSN Laboratories and Torrent Pharmaceuticals. ....
Clough inks hydrogen MoU in North America May 14, 2021 2:10:pm Summary by: Daniel Graeber Australian construction company Clough said May 11 it signed a preliminary agreement to build hydrogen processing plants in North America. Clough entered into a memorandum of understanding (MoU) with W. Posted in: ....
Canada’s Suncor, ATCO plan blue hydrogen project May 12, 2021 3:45:pm Summary by: Dale Lunan Canadian integrated oil and gas producer Suncor Energy and Alberta utility ATCO said May 11 they were in the early design and engineering stages for a project near Edmonton that would produce 300,000 mt/yr of blue hydrogen and reduce the province’s CO2 emissions by more than 2mn . Posted in: ....
Investors rushed to pick shares of Natco Pharma on the BSE on Monday as the firm sought Central Drugs Standard Control Organization s (CDSCO s) for approval of Phase-III clinical trial of Molnupiravir Capsules for the treatment of Covid-19 positive patients. At 11:30 am, shares of the pharmaceutical firm were ruling 5 per cent higher on the BSE, at Rs 923 apiece, as against a 1.4 per cent rise in the benchmark S&P BSE Sensex. In the intra-day deals, the shares surged 7.5 per cent to Rs 944 per share on the BSE. Pre-clinical data have shown that Molnupiravir has broad anti-influenza activity, including highly potent inhibition of SARS-CoV-2 replication. Patients treated with Molnupiravir achieved response within 5 days of therapy indicating that the duration of treatment with Molnupiravir is short, with the additional advantage of being an oral therapy, the firm said in an exchange filing. ....